BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 14960146)

  • 1. Prevention of cardiovascular disease: an evidence-based clinical aid.
    Cradick NH
    Med J Aust; 2004 Feb; 180(4):197-8; author reply 198. PubMed ID: 14960146
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of cardiovascular events in diabetes.
    Malcolm J; Meggison H; Sigal R
    Clin Evid; 2003 Dec; (10):690-714. PubMed ID: 15555116
    [No Abstract]   [Full Text] [Related]  

  • 3. Living up to 100 years of Bayer Healthcare cardiovascular protection - Bayer Healthcare Cardiovascular : 20 years of participation in the South African cardiovascular community.
    Cardiovasc J Afr; 2009; 20(1):91-4. PubMed ID: 19287826
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin for the primary prevention of cardiovascular events: recommendations and rationale.
    U.S. Preventive Services Task Force
    Am J Nurs; 2002 Mar; 102(3):67, 69-70. PubMed ID: 11976531
    [No Abstract]   [Full Text] [Related]  

  • 5. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
    Morimoto T; Fukui T; Lee TH; Matsui K
    Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the risk/benefit profile before recommending aspirin for the primary prevention of cardiovascular events.
    Rodondi N; Bauer DC
    Am J Med; 2004 Oct; 117(7):528-30. PubMed ID: 15464713
    [No Abstract]   [Full Text] [Related]  

  • 7. [Primary prevention of cardiovascular disease].
    Gohlke H
    Dtsch Med Wochenschr; 2005 Jan; 130(1-2):38-43. PubMed ID: 15619173
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Arnaout A
    Clin Evid; 2006 Jun; (15):623-45. PubMed ID: 16973029
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical inquiries. Which healthy adults should take aspirin?
    Werner M; Kelsberg G; Weismantel AM; Aitken PV
    J Fam Pract; 2004 Feb; 53(2):146-50. PubMed ID: 14764301
    [No Abstract]   [Full Text] [Related]  

  • 10. Canadian Hypertension Education Program. Brief overview of 2004 recommendations.
    Campbell N;
    Can Fam Physician; 2004 Oct; 50():1411-5. PubMed ID: 15526879
    [No Abstract]   [Full Text] [Related]  

  • 11. Other studies show aspirin use is high.
    Brown J
    PLoS Med; 2006 Feb; 3(2):e110; author reply e109. PubMed ID: 16492077
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association Guidelines.
    Wenger NK
    Adv Chronic Kidney Dis; 2013 Sep; 20(5):419-22. PubMed ID: 23978547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Polypill in the prevention of cardiovascular disease.
    Wald DS; Wald NJ
    Prev Med; 2011 Jan; 52(1):16-7. PubMed ID: 21130112
    [No Abstract]   [Full Text] [Related]  

  • 14. [The polypill: not an effective strategy for reduction of cardiovascular disease].
    Westerweel PE; van Wijk JP; Verhaar MC
    Ned Tijdschr Geneeskd; 2005 Jul; 149(31):1741. PubMed ID: 16114291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of aspirin in the primary prevention of cardiovascular disease].
    Rodondi N; Cornuz J
    Rev Med Suisse; 2006 Mar; 2(56):646-51. PubMed ID: 16597054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the cardiovascular disease burden: justified means for getting to the end.
    Bikdeli B; Barreto-Filho JA
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):580-6. PubMed ID: 22811501
    [No Abstract]   [Full Text] [Related]  

  • 17. Aspirin and the prevention of cardiovascular disease in chronic kidney disease: time to move forward?
    Wali RK
    J Am Coll Cardiol; 2010 Sep; 56(12):966-8. PubMed ID: 20828649
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aspirin therapy for cardiovascular prevention in the diabetic patient: what have we learned from the evidence?].
    Legrand DA; Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1904-8. PubMed ID: 16972540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pharmacotherapy of arterial hypertension and the prevention of cardiovascular events. From evidence-based medicine to the new therapeutic opportunities].
    Taddei S
    Recenti Prog Med; 1999 Jan; 90(1):4-8. PubMed ID: 10193156
    [No Abstract]   [Full Text] [Related]  

  • 20. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
    Temizhan A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.